Edition:
United Kingdom

Laboratory Corporation of America Holdings (LH.N)

LH.N on New York Stock Exchange

186.94USD
20 Jul 2018
Change (% chg)

$-0.05 (-0.03%)
Prev Close
$186.99
Open
$185.76
Day's High
$188.30
Day's Low
$185.76
Volume
132,171
Avg. Vol
184,244
52-wk High
$190.35
52-wk Low
$147.19

Latest Key Developments (Source: Significant Developments)

LabCorp Launches Proprietary UltraQual Multiplex PCR Assay For HCV, HIV-1, HIV-2 And HBV
Wednesday, 27 Jun 2018 

June 27 (Reuters) - Laboratory Corporation of America Holdings ::LABCORP LAUNCHES PROPRIETARY ULTRAQUAL® MULTIPLEX PCR ASSAY FOR HCV, HIV-1, HIV-2 AND HBV.LABCORP - RECEIVED APPROVAL FROM U.S. FDA FOR ULTRAQUAL MULTIPLEX PCR ASSAY FOR HCV, HIV-1, HIV-2 AND HBV FOR SCREENING OF DONATED BLOOD PLASMA.  Full Article

UnitedHealthcare Renewed Strategic Partnership With LabCorp
Thursday, 24 May 2018 

May 24 (Reuters) - Laboratory Corporation of America Holdings ::UNITEDHEALTHCARE ESTABLISHES LONG-TERM STRATEGIC PARTNERSHIP WITH LABCORP.LABCORP - CO, UNITEDHEALTHCARE HAVE RENEWED THEIR LONG-TERM STRATEGIC PARTNERSHIP.  Full Article

Eurofins Scientific Acquires LabCorp's Food Testing And Consulting Business
Monday, 30 Apr 2018 

April 30 (Reuters) - EUROFINS SCIENTIFIC SE ::ACQUISITION OF LABCORP’S FOOD TESTING AND CONSULTING BUSINESS.TRANSACTION EXPECTED TO CLOSE IN Q3 OF 2018.AGREED ACQUISITION PRICE IS US$670M ON A CASH FREE DEBT FREE BASIS.  Full Article

Labcorp announces new expanded use for PD-L1 test with Bristol-Myers Squibb's Opdivo
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Laboratory Corporation Of America Holdings :Labcorp announces new expanded use for PD-L1 test with Bristol-Myers Squibb's Opdivo®.Laboratory Corporation Of America Holdings - ‍announced U.S. availability of PD-L1 ihc 28-8 pharmdx assay as complementary diagnostic for 2 indications in connection with use of Opdivo​.  Full Article

Labcorp - Co,‍ Capital Health announced that they have entered into a laboratory partnership​
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Laboratory Corporation Of America Holdings :Labcorp - Co,‍ Capital Health announced that they have entered into a laboratory partnership​.  Full Article

LabCorp reports Q3 adjusted earnings per share of $2.46
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Laboratory Corporation Of America Holdings :LabCorp announces record third quarter results and increases 2017 guidance.Q3 adjusted earnings per share $2.46.Q3 earnings per share $1.74.Q3 revenue $2.6 billion versus I/B/E/S view $2.55 billion.Q3 earnings per share view $2.39 -- Thomson Reuters I/B/E/S.Sees FY 2017 adjusted earnings per share $9.40 to $9.60.LabCorp - ‍backlog for covance drug development at end of quarter was $6.84 billion, which includes backlog from Chiltern acquisition of $1.0 billion ​.LabCorp - ‍expects approximately $2.7 billion of backlog in covance drug development to convert into revenue in next twelve months​.LabCorp - ‍sees 2017 free cash flow increased to $970 million to $1,010 million, up 8% to 13% over 2016​.LabCorp sees ‍for 2017 net revenue growth of 8.0% to 8.5% over 2016 net revenue of $9.44 billion​.FY2017 earnings per share view $9.50, revenue view $10.10 billion -- Thomson Reuters I/B/E/S.LabCorp says "‍revenue growth" in quarter "was negatively impacted by approximately 0.7% due to multiple hurricanes during quarter​".  Full Article

Walgreens, Labcorp collaborate to bring patient service centers for laboratory testing to select Walgreens stores
Wednesday, 28 Jun 2017 

June 28 (Reuters) - Walgreens Boots Alliance Inc: :Walgreens and Labcorp collaborate to bring patient service centers for laboratory testing to select Walgreens stores.Walgreens Boots Alliance Inc - seven service centers planned to open at Walgreens stores in 2017.  Full Article

Shore Capital Partners announces sale of Clearpath Diagnostics to LabCorp
Tuesday, 4 Oct 2016 

Shore Capital Partners: Shore Capital Partners announces sale of Clearpath Diagnostics .Terms of transaction were not disclosed.  Full Article

Oxford Immunotec announces favorable recommendation by the magistrate judge
Thursday, 1 Sep 2016 

Oxford Immunotec Global PLC : Oxford Immunotec announces favorable recommendation by the magistrate judge in patent infringement litigation . Says recommendation denying in substantial part defendants' motion to dismiss company's claims . Patent infringement lawsuit against Qiagen Inc, Quest Diagnostics Inc and Laboratory Corporation of America Holdings .Says recommendation should now "allow company to press forward with its case against three defendants".  Full Article

Labcorp's acquisition of Sequenom clears antitrust review
Tuesday, 23 Aug 2016 

Laboratory Corporation Of America Holdings : Labcorp's acquisition of Sequenom clears antitrust review .Scott-Rodino antitrust improvements act of 1976 applicable to acquisition of Sequenom Inc by co has expired.  Full Article